BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
DRD2
,
G-protein-coupled receptor binding
,
Inflammatory disorder
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptor ligand activity
(biogroup)
NextBio Summary
General Info
Body Atlas
Most Correlated Tissues
Kidney medulla
Kidney cortex
Myometrium
Corpus callosum
Cerebral cortex
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Injury of external ear
Legionella infection
Severe acute respiratory syndrome
Viral disease
Infection due to Haemophilus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
tivozanib
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
ARQ 197
KW 2449
CGP 60474
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
ANKRD2
TLK2
BCKDK
DIDO1
CRKL
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts
L1000 CMAP - Pancreatic cancer YAPC.311 cells with CRISPR-targeted gene knockouts
L1000 CMAP - Colorectal cancer HT29.311 cells with CRISPR-targeted gene knockouts
L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens
L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Orvinols with mixed kappa/mu opioid receptor agonist activity.
Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity.
Alpha-1-adrenergic receptor agonist activity of clinical alpha-adrenergic receptor agonists interfer…
A continued saga of Boc5, the first non-peptidic glucagon-like peptide-1 receptor agonist with in vi…
The FomA porin from Fusobacterium nucleatum is a Toll-like receptor 2 agonist with immune adjuvant a…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunother…
NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand …
FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy
Study of the Effects of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent Provirus
Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Patients With Acromegaly Being Treated With L…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ